Bullish case
$210 to $230
More likely if organic revenue growth stays near the mid-single digits, operating margins hold, integration costs fade, buybacks continue, and the market keeps valuing MRSH near a premium earnings multiple.
Marsh & McLennan Companies, Inc. research snapshot
MRSH AI Stock Analysis
MRSH AI stock analysis currently reads Marsh & McLennan Companies, Inc. as a high-quality professional services and insurance advisory business with durable client relationships, strong free cash flow, and meaningful debt from acquisition activity. The page uses a scenario framework, not a certain price prediction. At the July 8, 2026 cutoff, the quoted price was $178.00, market capitalization was about $85.77 billion, and the main decision point was whether the quality of the business justifies a mid-20s earnings multiple after a weak one-year price trend. This is informational research and not investment advice.
Current price
$178.00
Market cap
$85.77 billion
AI score
68 / 100
Rating
High-quality advisory compounder, valuation and insurance-cycle risk
Trend status
Recovering above key moving averages but still below its 52-week high
Data cutoff (updated weekly)
July 8, 2026
Informational use only. This page is not investment advice.
Research quality check
- information Richness
- A-level information richness. Marsh has long public filings, audited segment disclosures, current quote pages, and several independent financial data sources.
- bias Check
- The main AI bias risk is consensus quality bias. Marsh looks like a steady compounder, so the analysis stresses downside paths: insurance cycle pressure, slower consulting demand, acquisition integration, debt, and valuation compression.
- ai Confidence
- High data confidence
- investment Certainty
- Medium. The business evidence is strong, but the stock outcome depends on future organic growth, margin durability, interest costs, and the price paid.
Quick verdict table
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Marsh sells risk advice, insurance brokerage, reinsurance, employee benefits, wealth, and management consulting services to clients that need specialized expertise. | High |
| Moat | Moat comes from global scale, carrier relationships, client data, specialized advisory talent, trusted brands, and recurring brokerage workflows. | High |
| Management | Management has a record of acquisition integration, buybacks, dividends, and steady segment execution, but debt and deal discipline remain important checks. | Medium-high |
| Financial trend | 2025 revenue was about $26.98 billion and net income was about $4.2 billion, with source checks showing consistent reported figures. | High |
| Valuation | At roughly 22.3x TTM EPS and 17.2x free cash flow per share, the stock prices in resilience and moderate growth rather than deep value. | Medium-high |
| Technical trend | The latest technical snapshot is improving: price is above the reported 50-day and 200-day moving averages, while the one-year change remains negative. | Medium |
| Risk level | Risk is medium because the business is resilient, but valuation, debt, acquisition execution, and soft insurance pricing can still reset expectations. | Medium-high |
| AI confidence | High confidence for current financial and quote context; lower confidence for future multiples and market sentiment. | High data confidence |
| Investment certainty | Medium certainty. The company quality is clearer than the margin of safety at the current price. | Medium |
MRSH AI stock forecast
MRSH AI Stock Forecast Scenarios
The MRSH AI stock forecast uses scenario ranges around the $178.00 quote rather than a single target. A three-year EPS and multiple model produced a bullish value near $228.40, a base value near $174.60, and a bearish value near $116.70. These ranges are planning scenarios, not promises.
Base case
$165 to $185
More likely if revenue grows steadily but valuation remains range-bound around 20x earnings while investors wait for proof that 2026 earnings can reaccelerate.
Bearish case
$115 to $140
More likely if insurance pricing weakens, consulting demand slows, debt costs pressure free cash flow, or investors reduce the earnings multiple toward the mid-teens.
MRSH AI technical analysis
MRSH AI Technical Analysis
MRSH AI technical analysis starts from the $178.00 quote and the July 8, 2026 market snapshot. The stock was above reported 50-day and 200-day moving averages, RSI was neutral to mildly positive, and volume was below the three-month average. Confirm live chart data before trading.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $178.00 | Current quote used for this page as of the July 8, 2026 data cutoff. |
| Near support | $172.26 to $174.59 | Support zone from recent moving-average and accumulated-volume references. A break below this zone would weaken the short-term setup. |
| Near resistance | $179.81 to $199.43 | The first resistance is the recent day high. The higher reference is an analyst-target snapshot and should not be treated as a guarantee. |
| 50-day moving average | About $168.57 | Reported technical snapshot placed price above the 50-day moving average, a positive but lagging signal. |
| 200-day moving average | About $164.77 | Reported technical snapshot placed price above the 200-day moving average, suggesting the rebound has improved from the prior downtrend. |
| Momentum | RSI near 57 to 60 | Momentum was positive but not overbought in the available technical snapshots. |
| Volume | 1.83 million versus 2.83 million average | Below-average volume means the rebound should be confirmed with follow-through before treating it as durable. |
| Volatility | Medium | The July 8 snapshot showed a 2.2% intraday range, suitable for predefined position sizing rather than loose risk controls. |
| Invalidation | Close below $172 | A decisive close below support would weaken the short-term trend-following case. |
MRSH AI trading strategy
MRSH AI Trading Strategy Framework
The MRSH AI trading strategy is a rules-based research framework. It is not personalized advice and should be paired with position sizing, stop levels, and fresh filings or news checks.
Trend-following setup
Wait for MRSH to hold above the $172 to $175 support zone, then look for a close above the $180 area with volume closer to or above the three-month average.
Invalidate the setup on a close below $172 or if the next earnings report shows weaker organic growth and margin pressure.
Mean-reversion setup
If MRSH pulls back toward the 50-day moving average without a business thesis break, compare price action with free cash flow, debt, and segment growth evidence.
Do not average down unless valuation, leverage, and the insurance pricing cycle still support the original thesis.
Fundamental monitor
Track Risk and Insurance Services growth, Consulting growth, acquisition integration, debt reduction, buybacks, and free cash flow conversion.
Reduce confidence if price strength is not supported by organic revenue, margin, and cash flow data.
Investment research summary
Four-master Research Compression
Business essence
Clients pay Marsh to reduce risk, place insurance, access reinsurance markets, manage people and wealth decisions, and solve management problems where specialist knowledge matters.
Moat
The moat is built on trust, scale, insurer and reinsurer relationships, advisory talent, data, and switching costs created by recurring client workflows.
Munger risk inversion
The thesis can fail if insurance pricing softens, consulting budgets tighten, acquisition integration disappoints, debt costs stay high, or the market compresses the valuation multiple.
Management
Management is judged by organic growth, capital allocation, deal discipline, debt control, buyback timing, dividend growth, and retention of specialist talent.
Industry trend
Complex risk, climate exposure, cyber risk, employee benefits, and reinsurance demand support the long-term advisory need, though pricing cycles still matter.
Valuation and margin of safety
The current price gives credit for a resilient franchise. Margin of safety improves if free cash flow grows while leverage falls, or if the stock rerates lower without a thesis break.
Source-backed data
MRSH Data Table
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| MRSH price | $178.00 | Investing.com quote snapshot | July 8, 2026 |
| Market capitalization | $85.77 billion, verified as $178.00 x 481.79 million shares with 0.01% variance | financial_rigor.py market cap verification and Robinhood quote snapshot | July 8, 2026 |
| Shares outstanding | About 481.79 million to 483.1 million | Morningstar and Investing.com quote snapshots | July 8, 2026 |
| 2025 revenue | $26.98 billion, cross-validated against company annual report, StockAnalysis, and StockTitan | Marsh 2025 annual report and StockAnalysis financials | July 8, 2026 |
| 2025 net income | About $4.2 billion, cross-validated against company annual report and StockTitan | Marsh 2025 annual report and StockTitan financials | July 8, 2026 |
| Cash and debt | About $2.69 billion cash and equivalents; total consolidated debt about $19.6 billion at fiscal 2025 year end | Marsh 2025 annual report | July 8, 2026 |
| TTM valuation snapshot | 22.28x PE, 5.89x PB, 17.15x P/FCF, 5.83% FCF yield, 1.93% dividend yield | financial_rigor.py valuation verification using Investing.com and StockTitan inputs | July 8, 2026 |
| Segment trend | Nine-month 2025 consolidated revenue grew 11% reported and 4% underlying; Risk and Insurance Services grew 13% reported | SEC Form 10-Q for quarter ended September 30, 2025 | July 8, 2026 |
| Technical snapshot | RSI about 57 to 60, 50-day moving average about $168.57, 200-day moving average about $164.77 | Investing.com technical snapshot | July 8, 2026 |
| Ticker context | NYSE ticker changed to MRSH on January 14, 2026 | Marsh 2025 annual report | July 8, 2026 |
Frequently Asked Questions
Use Pineify AI Stock PickerBuild an AI trading strategyRun an AI stock screenerRead the JPM AI stock analysis
This MRSH AI stock analysis page is an informational tool only. It is not investment advice, a recommendation, or a promise of future returns. Forecast scenarios are based on available data as of July 8, 2026, may be incomplete, and can be wrong if new filings, market prices, company events, or macro conditions change.